ACO2
Aconitate hydratase, mitochondrial
Also known as: ACON_HUMAN, ACONM
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99798
- Gene
- ACO2
- Ensembl
- ENSG00000100412
- Chromosome
- 22
- Canonical length
- 780 aa
- Protein class
- Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
The protein encoded by this gene belongs to the aconitase/IPM isomerase family. It is an enzyme that catalyzes the interconversion of citrate to isocitrate via cis-aconitate in the second step of the TCA cycle. This protein is encoded in the nucleus and functions in the mitochondrion. It was found to be one of the mitochondrial matrix proteins that are preferentially degraded by the serine protease 15(PRSS15), also known as Lon protease, after oxidative modification. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
780 residues, UniProt reviewed canonical sequence.
>Q99798|ACO2
1 MAPYSLLVTR LQKALGVRQY HVASVLCQRA KVAMSHFEPN EYIHYDLLEK NINIVRKRLN
61 RPLTLSEKIV YGHLDDPASQ EIERGKSYLR LRPDRVAMQD ATAQMAMLQF ISSGLSKVAV
121 PSTIHCDHLI EAQVGGEKDL RRAKDINQEV YNFLATAGAK YGVGFWKPGS GIIHQIILEN
181 YAYPGVLLIG TDSHTPNGGG LGGICIGVGG ADAVDVMAGI PWELKCPKVI GVKLTGSLSG
241 WSSPKDVILK VAGILTVKGG TGAIVEYHGP GVDSISCTGM ATICNMGAEI GATTSVFPYN
301 HRMKKYLSKT GREDIANLAD EFKDHLVPDP GCHYDQLIEI NLSELKPHIN GPFTPDLAHP
361 VAEVGKVAEK EGWPLDIRVG LIGSCTNSSY EDMGRSAAVA KQALAHGLKC KSQFTITPGS
421 EQIRATIERD GYAQILRDLG GIVLANACGP CIGQWDRKDI KKGEKNTIVT SYNRNFTGRN
481 DANPETHAFV TSPEIVTALA IAGTLKFNPE TDYLTGTDGK KFRLEAPDAD ELPKGEFDPG
541 QDTYQHPPKD SSGQHVDVSP TSQRLQLLEP FDKWDGKDLE DLQILIKVKG KCTTDHISAA
601 GPWLKFRGHL DNISNNLLIG AINIENGKAN SVRNAVTQEF GPVPDTARYY KKHGIRWVVI
661 GDENYGEGSS REHAALEPRH LGGRAIITKS FARIHETNLK KQGLLPLTFA DPADYNKIHP
721 VDKLTIQGLK DFTPGKPLKC IIKHPNGTQE TILLNHTFNE TQIEWFRAGS ALNRMKELQQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACO2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.2
- Highest tissue expression
- 650 nTPM
Expression across tissuesHPA
Tissue
- tongue: 650 nTPM
- skeletal muscle: 619 nTPM
- heart muscle: 463 nTPM
- parathyroid gland: 220 nTPM
- cerebral cortex: 205 nTPM
- choroid plexus: 172 nTPM
Single-cell type
- enterocytes: 479 nCPM
- myonuclei: 313 nCPM
- syncytiotrophoblasts: 312 nCPM
- parietal cells: 256 nCPM
- colonocytes: 237 nCPM
- rod photoreceptor cells: 201 nCPM
Immune cell
- non-classical monocyte: 98 nTPM
- intermediate monocyte: 76 nTPM
- myeloid DC: 69 nTPM
- total PBMC: 59 nTPM
- classical monocyte: 53 nTPM
- memory B-cell: 50 nTPM
Brain region
- thalamus: 248 nTPM
- cerebral cortex: 213 nTPM
- choroid plexus: 189 nTPM
- white matter: 180 nTPM
- amygdala: 176 nTPM
- hippocampal formation: 176 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACO2.
Disease | AllUniProt
Conditions ACO2 is implicated in, by any mechanism.
- Infantile cerebellar-retinal degeneration (ICRD) MIM:614559
- Optic atrophy 9 (OPA9) MIM:616289
Disease | GeneticClinVar
83 pathogenic / likely-pathogenic of 907 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Infantile cerebellar-retinal degeneration
- Optic atrophy 9
- Optic atrophy
- ACO2-related disorder
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.21
- gnomAD missense Z
- 2.92
- DepMap mean gene effect
- -0.76
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aconitase A/isopropylmalate dehydratase small subunit, swivel domain
- Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha domain
- Aconitase/3-isopropylmalate dehydratase, swivel
- Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha, subdomain 1/3
- Aconitase family, 4Fe-4S cluster binding site
- Aconitase, iron-sulfur domain
- Aconitase family (aconitate hydratase)
- Aconitase C-terminal domain
- Aconitase, mitochondrial-like
- Aconitase, domain 2
- Aconitase/IPM Isomerase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ACO2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACO2 as an antibody target. Whether an autoantibody or antibody against ACO2 could matter depends on whether native ACO2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACO2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACO2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...